Clinical recombinant biological products or suitable recombinant biologicals
The agency (MHRA) is looking for suppliers/distributors able to provide Clinical recombinant biological products or suitable recombinant biological used for CMC activities (Chemistry, Manufacturing, and Control) for the following biotherapeutic innovator monoclonal antibody and/or biosimilar. This requirement is mainly for RESEARCH USE ONLY and NOT for Whole Sale but NOT limited to this usage. It may be also used to develop reference materials and/or standards for distribution. We are looking for 1 to 5 batches of...
Buyer
Medicines and Healthcare Products Regulatory Agency
Value
Not provided
Published
10 Jul 2018
Closes
10 Jul 2018
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
24000000
Chemical products
Lots
Lot default Clinical recombinant biological products or suitable recombinant biologicals
Value not provided
The agency (MHRA) is looking for suppliers/distributors able to provide Clinical recombinant biological products or suitable recombinant biological used for CMC activities (Chemistry, Manufacturing, and Control) for the following biotherapeutic innovator monoclonal antibody and/or biosimilar. This requirement is mainly for RESEARCH USE ONLY and NOT for Whole...
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
10 Jul 2018
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.